Area of research
Immunology · Oncology
Research interest
Research interests include Immunotherapy and Immune Responses, MicroRNA in disease regulation, RNA Interference and Gene Delivery, and CAR-T cell therapy research.
MicroRNAs affecting the susceptibility of melanoma cells to CD8<sup>+</sup> T cell‐mediated cytolysis
Novel microRNAs modulating ecto-5′-nucleotidase expression
Antigen presentation safeguards the integrity of the hematopoietic stem cell pool
Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model
SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines
Adoptively Transferred in vitro-Generated Myeloid-Derived Suppressor Cells Improve T-Cell Function and Antigen-Specific Immunity after Traumatic Lung Injury
SOX9 is a Target of miR-134-3p And miR-224-3p in Beast Cancer Cell Lines
Reprogramming of macrophages employing gene regulatory and metabolic network models
Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell lines
Measles Vaccines Designed for Enhanced CD8+ T Cell Activation
Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line
Combined prophylactic and therapeutic immune responses against human papillomaviruses induced by a thioredoxin-based L2-E7 nanoparticle vaccine
Cognate Interaction With CD4+ T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype
Reprogramming of M2-like macrophages to M1-like phenotype by tumor-antigen specific CD4+ T cells
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice
Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E
MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion
miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion <i>in vitro</i>
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
miR-339-3p Is a Tumor Suppressor in Melanoma
Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy
Abstract 1987: Molecular characterization of the breast cancer-associated antigen NY-BR-1
Abstract 5012: Establishment of a transplantable, NY-BR-1 expressing breast cancer model in HLA-transgenic mice
Abstract 3109: A functional microRNA screening approach that identifies microRNAs affecting melanoma cell invasion
Abstract 3154: Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1
The role of microRNAs in melanoma
Identification of NY‐BR‐1‐specific CD4<sup>+</sup> T cell epitopes using HLA‐transgenic mice
Abstract 1259: Murine HLA-restricted CD4+ T cell lines as source of high affinity TCRs specific for the human breast cancer-associated tumor antigen NY-BR-1.
T-Cell Mediated Immune Responses Induced in ret Transgenic Mouse Model of Malignant Melanoma